CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale Director sold 15,174 shares at an average $46.17 ($700,515)
- 4 Open-market sale Director sold 11,670 shares at $43.95 ($512,840)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at $43.67 ($218,346)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $45.29 ($62,274)
- 4 Open-market sale Director sold 11,670 shares at $44.56 ($520,033)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $41.49 ($414,874)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $42.51 ($58,451)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Grant or award Director acquired 3,374 shares (grant or award)
- 4 Open-market sale Director sold 11,670 shares at an average $44.50 ($519,351)
- 4 Open-market sale Director sold 10,000 shares at $43.73 ($437,275)
- 4 Open-market sale Director sold 15,174 shares at an average $43.80 ($664,601)
Page 17 of 25 · 491 filings